Global Anti-Smoking Products Market 2022 by Company, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 101616
  • calendar_today Published On: Mar, 2022
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Anti-Smoking Products market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Anti-Smoking Products market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Smokers aged 18–24 accounting for % of the Anti-Smoking Products global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Nicotine Replacement Therapy segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Anti-Smoking Products include Pfizer, Cipla, Novartis International, GSK, and Takeda pharmaceutical, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Anti-Smoking Products market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Nicotine Replacement Therapy

Drug therapy

E-cigarettes

Market segment by Application, can be divided into

Smokers aged 18–24

Smokers aged 25–44

Smokers aged 45–64

Smokers aged 65 years or older

Market segment by players, this report covers

Pfizer

Cipla

Novartis International

GSK

Takeda pharmaceutical

McNeil AB

Revolymer plc

Imperial Tobacco

Elder Pharma

NJOY

VMR products

Lorillard

VaporCorp

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Anti-Smoking Products product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Anti-Smoking Products, with revenue, gross margin and global market share of Anti-Smoking Products from 2019 to 2022.

Chapter 3, the Anti-Smoking Products competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Anti-Smoking Products market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Anti-Smoking Products research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1 Market Overview

1.1 Product Overview and Scope of Anti-Smoking Products

1.2 Classification of Anti-Smoking Products by Type

1.2.1 Overview: Global Anti-Smoking Products Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Anti-Smoking Products Revenue Market Share by Type in 2021

1.2.3 Nicotine Replacement Therapy

1.2.4 Drug therapy

1.2.5 E-cigarettes

1.3 Global Anti-Smoking Products Market by Application

1.3.1 Overview: Global Anti-Smoking Products Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Smokers aged 18–24

1.3.3 Smokers aged 25–44

1.3.4 Smokers aged 45–64

1.3.5 Smokers aged 65 years or older

1.4 Global Anti-Smoking Products Market Size & Forecast

1.5 Global Anti-Smoking Products Market Size and Forecast by Region

1.5.1 Global Anti-Smoking Products Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Anti-Smoking Products Market Size by Region, (2017-2022)

1.5.3 North America Anti-Smoking Products Market Size and Prospect (2017-2028)

1.5.4 Europe Anti-Smoking Products Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Anti-Smoking Products Market Size and Prospect (2017-2028)

1.5.6 South America Anti-Smoking Products Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Anti-Smoking Products Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Anti-Smoking Products Market Drivers

1.6.2 Anti-Smoking Products Market Restraints

1.6.3 Anti-Smoking Products Trends Analysis

2 Company Profiles

2 Company Profiles

2.1 Pfizer

2.1.1 Pfizer Details

2.1.2 Pfizer Major Business

2.1.3 Pfizer Anti-Smoking Products Product and Solutions

2.1.4 Pfizer Anti-Smoking Products Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Pfizer Recent Developments and Future Plans

2.2 Cipla

2.2.1 Cipla Details

2.2.2 Cipla Major Business

2.2.3 Cipla Anti-Smoking Products Product and Solutions

2.2.4 Cipla Anti-Smoking Products Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Cipla Recent Developments and Future Plans

2.3 Novartis International

2.3.1 Novartis International Details

2.3.2 Novartis International Major Business

2.3.3 Novartis International Anti-Smoking Products Product and Solutions

2.3.4 Novartis International Anti-Smoking Products Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Novartis International Recent Developments and Future Plans

2.4 GSK

2.4.1 GSK Details

2.4.2 GSK Major Business

2.4.3 GSK Anti-Smoking Products Product and Solutions

2.4.4 GSK Anti-Smoking Products Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 GSK Recent Developments and Future Plans

2.5 Takeda pharmaceutical

2.5.1 Takeda pharmaceutical Details

2.5.2 Takeda pharmaceutical Major Business

2.5.3 Takeda pharmaceutical Anti-Smoking Products Product and Solutions

2.5.4 Takeda pharmaceutical Anti-Smoking Products Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Takeda pharmaceutical Recent Developments and Future Plans

2.6 McNeil AB

2.6.1 McNeil AB Details

2.6.2 McNeil AB Major Business

2.6.3 McNeil AB Anti-Smoking Products Product and Solutions

2.6.4 McNeil AB Anti-Smoking Products Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 McNeil AB Recent Developments and Future Plans

2.7 Revolymer plc

2.7.1 Revolymer plc Details

2.7.2 Revolymer plc Major Business

2.7.3 Revolymer plc Anti-Smoking Products Product and Solutions

2.7.4 Revolymer plc Anti-Smoking Products Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Revolymer plc Recent Developments and Future Plans

2.8 Imperial Tobacco

2.8.1 Imperial Tobacco Details

2.8.2 Imperial Tobacco Major Business

2.8.3 Imperial Tobacco Anti-Smoking Products Product and Solutions

2.8.4 Imperial Tobacco Anti-Smoking Products Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Imperial Tobacco Recent Developments and Future Plans

2.9 Elder Pharma

2.9.1 Elder Pharma Details

2.9.2 Elder Pharma Major Business

2.9.3 Elder Pharma Anti-Smoking Products Product and Solutions

2.9.4 Elder Pharma Anti-Smoking Products Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Elder Pharma Recent Developments and Future Plans

2.10 NJOY

2.10.1 NJOY Details

2.10.2 NJOY Major Business

2.10.3 NJOY Anti-Smoking Products Product and Solutions

2.10.4 NJOY Anti-Smoking Products Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 NJOY Recent Developments and Future Plans

2.11 VMR products

2.11.1 VMR products Details

2.11.2 VMR products Major Business

2.11.3 VMR products Anti-Smoking Products Product and Solutions

2.11.4 VMR products Anti-Smoking Products Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11.5 VMR products Recent Developments and Future Plans

2.12 Lorillard

2.12.1 Lorillard Details

2.12.2 Lorillard Major Business

2.12.3 Lorillard Anti-Smoking Products Product and Solutions

2.12.4 Lorillard Anti-Smoking Products Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.12.5 Lorillard Recent Developments and Future Plans

2.13 VaporCorp

2.13.1 VaporCorp Details

2.13.2 VaporCorp Major Business

2.13.3 VaporCorp Anti-Smoking Products Product and Solutions

2.13.4 VaporCorp Anti-Smoking Products Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.13.5 VaporCorp Recent Developments and Future Plans

3 Market Competition, by Players

3 Market Competition, by Players

3.1 Global Anti-Smoking Products Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Anti-Smoking Products Players Market Share in 2021

3.2.2 Top 10 Anti-Smoking Products Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Anti-Smoking Products Players Head Office, Products and Services Provided

3.4 Anti-Smoking Products Mergers & Acquisitions

3.5 Anti-Smoking Products New Entrants and Expansion Plans

4 Market Size Segment by Type

4 Market Size Segment by Type

4.1 Global Anti-Smoking Products Revenue and Market Share by Type (2017-2022)

4.2 Global Anti-Smoking Products Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5 Market Size Segment by Application

5.1 Global Anti-Smoking Products Revenue Market Share by Application (2017-2022)

5.2 Global Anti-Smoking Products Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6 North America by Country, by Type, and by Application

6.1 North America Anti-Smoking Products Revenue by Type (2017-2028)

6.2 North America Anti-Smoking Products Revenue by Application (2017-2028)

6.3 North America Anti-Smoking Products Market Size by Country

6.3.1 North America Anti-Smoking Products Revenue by Country (2017-2028)

6.3.2 United States Anti-Smoking Products Market Size and Forecast (2017-2028)

6.3.3 Canada Anti-Smoking Products Market Size and Forecast (2017-2028)

6.3.4 Mexico Anti-Smoking Products Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7 Europe by Country, by Type, and by Application

7.1 Europe Anti-Smoking Products Revenue by Type (2017-2028)

7.2 Europe Anti-Smoking Products Revenue by Application (2017-2028)

7.3 Europe Anti-Smoking Products Market Size by Country

7.3.1 Europe Anti-Smoking Products Revenue by Country (2017-2028)

7.3.2 Germany Anti-Smoking Products Market Size and Forecast (2017-2028)

7.3.3 France Anti-Smoking Products Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Anti-Smoking Products Market Size and Forecast (2017-2028)

7.3.5 Russia Anti-Smoking Products Market Size and Forecast (2017-2028)

7.3.6 Italy Anti-Smoking Products Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Anti-Smoking Products Revenue by Type (2017-2028)

8.2 Asia-Pacific Anti-Smoking Products Revenue by Application (2017-2028)

8.3 Asia-Pacific Anti-Smoking Products Market Size by Region

8.3.1 Asia-Pacific Anti-Smoking Products Revenue by Region (2017-2028)

8.3.2 China Anti-Smoking Products Market Size and Forecast (2017-2028)

8.3.3 Japan Anti-Smoking Products Market Size and Forecast (2017-2028)

8.3.4 South Korea Anti-Smoking Products Market Size and Forecast (2017-2028)

8.3.5 India Anti-Smoking Products Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Anti-Smoking Products Market Size and Forecast (2017-2028)

8.3.7 Australia Anti-Smoking Products Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9 South America by Country, by Type, and by Application

9.1 South America Anti-Smoking Products Revenue by Type (2017-2028)

9.2 South America Anti-Smoking Products Revenue by Application (2017-2028)

9.3 South America Anti-Smoking Products Market Size by Country

9.3.1 South America Anti-Smoking Products Revenue by Country (2017-2028)

9.3.2 Brazil Anti-Smoking Products Market Size and Forecast (2017-2028)

9.3.3 Argentina Anti-Smoking Products Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Anti-Smoking Products Revenue by Type (2017-2028)

10.2 Middle East & Africa Anti-Smoking Products Revenue by Application (2017-2028)

10.3 Middle East & Africa Anti-Smoking Products Market Size by Country

10.3.1 Middle East & Africa Anti-Smoking Products Revenue by Country (2017-2028)

10.3.2 Turkey Anti-Smoking Products Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Anti-Smoking Products Market Size and Forecast (2017-2028)

10.3.4 UAE Anti-Smoking Products Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

11 Research Findings and Conclusion

12 Appendix

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Anti-Smoking Products Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Anti-Smoking Products Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Anti-Smoking Products Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Anti-Smoking Products Revenue (USD Million) by Region (2017-2022)

Table 5. Global Anti-Smoking Products Revenue Market Share by Region (2023-2028)

Table 6. Pfizer Corporate Information, Head Office, and Major Competitors

Table 7. Pfizer Major Business

Table 8. Pfizer Anti-Smoking Products Product and Solutions

Table 9. Pfizer Anti-Smoking Products Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Cipla Corporate Information, Head Office, and Major Competitors

Table 11. Cipla Major Business

Table 12. Cipla Anti-Smoking Products Product and Solutions

Table 13. Cipla Anti-Smoking Products Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Novartis International Corporate Information, Head Office, and Major Competitors

Table 15. Novartis International Major Business

Table 16. Novartis International Anti-Smoking Products Product and Solutions

Table 17. Novartis International Anti-Smoking Products Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. GSK Corporate Information, Head Office, and Major Competitors

Table 19. GSK Major Business

Table 20. GSK Anti-Smoking Products Product and Solutions

Table 21. GSK Anti-Smoking Products Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Takeda pharmaceutical Corporate Information, Head Office, and Major Competitors

Table 23. Takeda pharmaceutical Major Business

Table 24. Takeda pharmaceutical Anti-Smoking Products Product and Solutions

Table 25. Takeda pharmaceutical Anti-Smoking Products Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. McNeil AB Corporate Information, Head Office, and Major Competitors

Table 27. McNeil AB Major Business

Table 28. McNeil AB Anti-Smoking Products Product and Solutions

Table 29. McNeil AB Anti-Smoking Products Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Revolymer plc Corporate Information, Head Office, and Major Competitors

Table 31. Revolymer plc Major Business

Table 32. Revolymer plc Anti-Smoking Products Product and Solutions

Table 33. Revolymer plc Anti-Smoking Products Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Imperial Tobacco Corporate Information, Head Office, and Major Competitors

Table 35. Imperial Tobacco Major Business

Table 36. Imperial Tobacco Anti-Smoking Products Product and Solutions

Table 37. Imperial Tobacco Anti-Smoking Products Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Elder Pharma Corporate Information, Head Office, and Major Competitors

Table 39. Elder Pharma Major Business

Table 40. Elder Pharma Anti-Smoking Products Product and Solutions

Table 41. Elder Pharma Anti-Smoking Products Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. NJOY Corporate Information, Head Office, and Major Competitors

Table 43. NJOY Major Business

Table 44. NJOY Anti-Smoking Products Product and Solutions

Table 45. NJOY Anti-Smoking Products Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. VMR products Corporate Information, Head Office, and Major Competitors

Table 47. VMR products Major Business

Table 48. VMR products Anti-Smoking Products Product and Solutions

Table 49. VMR products Anti-Smoking Products Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 50. Lorillard Corporate Information, Head Office, and Major Competitors

Table 51. Lorillard Major Business

Table 52. Lorillard Anti-Smoking Products Product and Solutions

Table 53. Lorillard Anti-Smoking Products Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 54. VaporCorp Corporate Information, Head Office, and Major Competitors

Table 55. VaporCorp Major Business

Table 56. VaporCorp Anti-Smoking Products Product and Solutions

Table 57. VaporCorp Anti-Smoking Products Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 58. Global Anti-Smoking Products Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 59. Global Anti-Smoking Products Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 60. Breakdown of Anti-Smoking Products by Company Type (Tier 1, Tier 2 and Tier 3)

Table 61. Anti-Smoking Products Players Head Office, Products and Services Provided

Table 62. Anti-Smoking Products Mergers & Acquisitions in the Past Five Years

Table 63. Anti-Smoking Products New Entrants and Expansion Plans

Table 64. Global Anti-Smoking Products Revenue (USD Million) by Type (2017-2022)

Table 65. Global Anti-Smoking Products Revenue Share by Type (2017-2022)

Table 66. Global Anti-Smoking Products Revenue Forecast by Type (2023-2028)

Table 67. Global Anti-Smoking Products Revenue by Application (2017-2022)

Table 68. Global Anti-Smoking Products Revenue Forecast by Application (2023-2028)

Table 69. North America Anti-Smoking Products Revenue by Type (2017-2022) & (USD Million)

Table 70. North America Anti-Smoking Products Revenue by Type (2023-2028) & (USD Million)

Table 71. North America Anti-Smoking Products Revenue by Application (2017-2022) & (USD Million)

Table 72. North America Anti-Smoking Products Revenue by Application (2023-2028) & (USD Million)

Table 73. North America Anti-Smoking Products Revenue by Country (2017-2022) & (USD Million)

Table 74. North America Anti-Smoking Products Revenue by Country (2023-2028) & (USD Million)

Table 75. Europe Anti-Smoking Products Revenue by Type (2017-2022) & (USD Million)

Table 76. Europe Anti-Smoking Products Revenue by Type (2023-2028) & (USD Million)

Table 77. Europe Anti-Smoking Products Revenue by Application (2017-2022) & (USD Million)

Table 78. Europe Anti-Smoking Products Revenue by Application (2023-2028) & (USD Million)

Table 79. Europe Anti-Smoking Products Revenue by Country (2017-2022) & (USD Million)

Table 80. Europe Anti-Smoking Products Revenue by Country (2023-2028) & (USD Million)

Table 81. Asia-Pacific Anti-Smoking Products Revenue by Type (2017-2022) & (USD Million)

Table 82. Asia-Pacific Anti-Smoking Products Revenue by Type (2023-2028) & (USD Million)

Table 83. Asia-Pacific Anti-Smoking Products Revenue by Application (2017-2022) & (USD Million)

Table 84. Asia-Pacific Anti-Smoking Products Revenue by Application (2023-2028) & (USD Million)

Table 85. Asia-Pacific Anti-Smoking Products Revenue by Region (2017-2022) & (USD Million)

Table 86. Asia-Pacific Anti-Smoking Products Revenue by Region (2023-2028) & (USD Million)

Table 87. South America Anti-Smoking Products Revenue by Type (2017-2022) & (USD Million)

Table 88. South America Anti-Smoking Products Revenue by Type (2023-2028) & (USD Million)

Table 89. South America Anti-Smoking Products Revenue by Application (2017-2022) & (USD Million)

Table 90. South America Anti-Smoking Products Revenue by Application (2023-2028) & (USD Million)

Table 91. South America Anti-Smoking Products Revenue by Country (2017-2022) & (USD Million)

Table 92. South America Anti-Smoking Products Revenue by Country (2023-2028) & (USD Million)

Table 93. Middle East & Africa Anti-Smoking Products Revenue by Type (2017-2022) & (USD Million)

Table 94. Middle East & Africa Anti-Smoking Products Revenue by Type (2023-2028) & (USD Million)

Table 95. Middle East & Africa Anti-Smoking Products Revenue by Application (2017-2022) & (USD Million)

Table 96. Middle East & Africa Anti-Smoking Products Revenue by Application (2023-2028) & (USD Million)

Table 97. Middle East & Africa Anti-Smoking Products Revenue by Country (2017-2022) & (USD Million)

Table 98. Middle East & Africa Anti-Smoking Products Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Anti-Smoking Products Picture

Figure 2. Global Anti-Smoking Products Revenue Market Share by Type in 2021

Figure 3. Nicotine Replacement Therapy

Figure 4. Drug therapy

Figure 5. E-cigarettes

Figure 6. Anti-Smoking Products Revenue Market Share by Application in 2021

Figure 7. Smokers aged 18–24 Picture

Figure 8. Smokers aged 25–44 Picture

Figure 9. Smokers aged 45–64 Picture

Figure 10. Smokers aged 65 years or older Picture

Figure 11. Global Anti-Smoking Products Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 12. Global Anti-Smoking Products Revenue and Forecast (2017-2028) & (USD Million)

Figure 13. Global Anti-Smoking Products Revenue Market Share by Region (2017-2028)

Figure 14. Global Anti-Smoking Products Revenue Market Share by Region in 2021

Figure 15. North America Anti-Smoking Products Revenue (USD Million) and Growth Rate (2017-2028)

Figure 16. Europe Anti-Smoking Products Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. Asia-Pacific Anti-Smoking Products Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. South America Anti-Smoking Products Revenue (USD Million) and Growth Rate (2017-2028)

Figure 19. Middle East and Africa Anti-Smoking Products Revenue (USD Million) and Growth Rate (2017-2028)

Figure 20. Anti-Smoking Products Market Drivers

Figure 21. Anti-Smoking Products Market Restraints

Figure 22. Anti-Smoking Products Market Trends

Figure 23. Pfizer Recent Developments and Future Plans

Figure 24. Cipla Recent Developments and Future Plans

Figure 25. Novartis International Recent Developments and Future Plans

Figure 26. GSK Recent Developments and Future Plans

Figure 27. Takeda pharmaceutical Recent Developments and Future Plans

Figure 28. McNeil AB Recent Developments and Future Plans

Figure 29. Revolymer plc Recent Developments and Future Plans

Figure 30. Imperial Tobacco Recent Developments and Future Plans

Figure 31. Elder Pharma Recent Developments and Future Plans

Figure 32. NJOY Recent Developments and Future Plans

Figure 33. VMR products Recent Developments and Future Plans

Figure 34. Lorillard Recent Developments and Future Plans

Figure 35. VaporCorp Recent Developments and Future Plans

Figure 36. Global Anti-Smoking Products Revenue Share by Players in 2021

Figure 37. Anti-Smoking Products Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 38. Global Top 3 Players Anti-Smoking Products Revenue Market Share in 2021

Figure 39. Global Top 10 Players Anti-Smoking Products Revenue Market Share in 2021

Figure 40. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 41. Global Anti-Smoking Products Revenue Share by Type in 2021

Figure 42. Global Anti-Smoking Products Market Share Forecast by Type (2023-2028)

Figure 43. Global Anti-Smoking Products Revenue Share by Application in 2021

Figure 44. Global Anti-Smoking Products Market Share Forecast by Application (2023-2028)

Figure 45. North America Anti-Smoking Products Sales Market Share by Type (2017-2028)

Figure 46. North America Anti-Smoking Products Sales Market Share by Application (2017-2028)

Figure 47. North America Anti-Smoking Products Revenue Market Share by Country (2017-2028)

Figure 48. United States Anti-Smoking Products Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 49. Canada Anti-Smoking Products Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 50. Mexico Anti-Smoking Products Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 51. Europe Anti-Smoking Products Sales Market Share by Type (2017-2028)

Figure 52. Europe Anti-Smoking Products Sales Market Share by Application (2017-2028)

Figure 53. Europe Anti-Smoking Products Revenue Market Share by Country (2017-2028)

Figure 54. Germany Anti-Smoking Products Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 55. France Anti-Smoking Products Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. United Kingdom Anti-Smoking Products Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. Russia Anti-Smoking Products Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 58. Italy Anti-Smoking Products Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. Asia-Pacific Anti-Smoking Products Sales Market Share by Type (2017-2028)

Figure 60. Asia-Pacific Anti-Smoking Products Sales Market Share by Application (2017-2028)

Figure 61. Asia-Pacific Anti-Smoking Products Revenue Market Share by Region (2017-2028)

Figure 62. China Anti-Smoking Products Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. Japan Anti-Smoking Products Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. South Korea Anti-Smoking Products Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. India Anti-Smoking Products Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. Southeast Asia Anti-Smoking Products Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. Australia Anti-Smoking Products Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. South America Anti-Smoking Products Sales Market Share by Type (2017-2028)

Figure 69. South America Anti-Smoking Products Sales Market Share by Application (2017-2028)

Figure 70. South America Anti-Smoking Products Revenue Market Share by Country (2017-2028)

Figure 71. Brazil Anti-Smoking Products Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 72. Argentina Anti-Smoking Products Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 73. Middle East and Africa Anti-Smoking Products Sales Market Share by Type (2017-2028)

Figure 74. Middle East and Africa Anti-Smoking Products Sales Market Share by Application (2017-2028)

Figure 75. Middle East and Africa Anti-Smoking Products Revenue Market Share by Country (2017-2028)

Figure 76. Turkey Anti-Smoking Products Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 77. Saudi Arabia Anti-Smoking Products Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 78. UAE Anti-Smoking Products Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 79. Methodology

Figure 80. Research Process and Data Source